NCT06866977View on ClinicalTrials.gov

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pancreatic Cancer
Interventions
DRUG

Oncolytic virus VRT106

VRT106, IV

DRUG

Chemotherapy

21 days/cycle

Trial Locations (1)

Unknown

Xiangya Hospital of Central South University, Changsha

Sponsors
All Listed Sponsors
collaborator

Guangzhou Virotech Pharmaceutical Co., Ltd.

INDUSTRY

lead

Xiangya Hospital of Central South University

OTHER

NCT06866977 - A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter